Exercise Price Adjustment for 5th Series BW from 4,043 KRW to 2,831 KRW, Potential Dilution of 16% Raises Concerns for Existing Shareholders


  • Due to market price decline, the exercise price of the 5th series bonds with warrants was adjusted downward by 30% from 4,043 KRW to 2,831 KRW.
  • The number of exercisable shares increased from approximately 2.73 million to 3.89 million, representing a potential dilution of about 16% of outstanding shares.
  • This adjustment is automatic per the bond terms without a separate board resolution.
  • [AI Summary]The downward adjustment of the warrant exercise price substantially increases potential equity dilution, threatening existing shareholder value and likely exerting downward pressure on the stock price.

KOSDAQ Filing Information


  • Adjustment of Exercise Price of Stock Subscription Rights
  • Company: Green Cross Medical Science (142280)
  • Submission: Green Cross Medical Science Corporation
  • Under KRX KOSDAQ Market Division

  • Shares: 23,963,031
  • Price: 2,750 KRW
  • Market Cap: 65.9 B KRW